HILLSTREAM BIOPHARMA INC's ticker is and the CUSIP is 432705101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,813 | -40.1% | 19,067 | +9.4% | 0.00% | – |
| Q2 2023 | $6,361 | +70577.8% | 17,427 | +47.3% | 0.00% | – |
| Q1 2023 | $9 | +125.0% | 11,828 | +30.7% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 9,050 | +6.1% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 8,531 | +85.3% | 0.00% | – |
| Q2 2022 | $4,000 | -69.2% | 4,605 | -43.2% | 0.00% | – |
| Q1 2022 | $13,000 | – | 8,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 26,200 | $10 | 0.00% |
| UBS Group AG | 11,437 | $4,460 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,000 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 31 | $12 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 12,252 | $4,706 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 21,357 | $8,325 | 0.00% |
| Tower Research Capital LLC (TRC) | 9,050 | $4 | 0.00% |